Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, et al. Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer. JAMA Oncol. 2018;4:1066–72.
Google Scholar
Costanzo S, Godino L, De Summa S, Marvulli TM, Genuardi M, Di Pietro ML, et al. BRCA cascade counselling and testing in Italy: current position and future directions. BMC Cancer. 2025;25:1044.
Google Scholar
Padmanabhan H, Mariapun S, Lee SY, Hassan NT, Lee DSC, Meiser B, et al. Impact of BRCA1/2 cascade testing on anxiety, depression, and cancer worry levels among unaffected relatives in a multiethnic Asian cohort. J Genet Couns. 2023;32:43–56.
Google Scholar
Isselhard A, Lautz Z, Rhiem K, Stock S. Assessing psychological morbidity in cancer-unaffected BRCA1/2 pathogenic variant carriers: a systematic review. Curr Oncol. 2023;30:3590–608.
Google Scholar
Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med. 2006;42:401–8.
Google Scholar
Oliveira FFB, de Barros Silva PG, de Sant’Ana RO, de Albuquerque CGP, Bezerra MJB, Wong DVT, et al. How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial. Support Care Cancer. 2021;29:3521–30.
Google Scholar
Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, et al. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology. 2018;27:1530–7.
Google Scholar
López-Fernández A, Villacampa G, Salinas M, Grau E, Darder E, Carrasco E, et al. Role of psychological background in cancer susceptibility genetic testing distress: it is not only about a positive result. J Genet Couns. 2023;32:778–87.
Google Scholar
Carlsson L, Thain E, Gillies B, Metcalfe K. Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature. Hered Cancer Clin Pr. 2022;20:25.
Google Scholar
Koptiuch C, Espinel WF, Kohlmann WK, Zhao J, Kaphingst KA. Implications of multigene panel testing on psychosocial outcomes: a comparison of patients with pancreatic and breast or ovarian cancer. JCO Precis Oncol. 2021;5:PO.20.00199.
Carlsson L, Bedard PL, Kim RH, Metcalfe K. Psychological distress following multi-gene panel testing for hereditary breast and ovarian cancer risk. J Genet Couns. 2025;34:e1940.
Google Scholar
FORCE. Paying for Genetic Services. 2025. https://www.facingourrisk.org/support/insurance-paying-for-care/paying-for-genetic-services.
NHS England website. National genomic test directory. 2025. https://www.england.nhs.uk/publication/national-genomic-test-directories/.
Japan Organization of Hereditary Breast and Ovarian Cancer, editor. Guidelines for diagnosis and treatment of hereditary breast and ovarian cancer 2024. Tokyo: Kanehara; 2024. p.54–61
National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf 2026.
Heald B, Pirzadeh-Miller S, Ellsworth RE, Nielsen SM, Russell EM, Beitsch P, et al. Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives. J Natl Cancer Inst. 2024;116:334–7.
Google Scholar
Caswell-Jin JL, Zimmer AD, Stedden W, Kingham KE, Zhou AY, Kurian AW. Cascade genetic testing of relatives for hereditary cancer risk: results of an online initiative. J Natl Cancer Inst. 2019;111:95–8.
Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Google Scholar
Custers JAE, Gielissen MFM, Janssen SHV, de Wilt JHW, Prins JB. Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer. 2016;24:555–62.
Google Scholar
Otsuka YFT. Development of Japanese version of the cancer worry scale and examination of its validity and reliability. J Hum Sci. 2020;28:22–8.
Douma KFL, Aaronson NK, Vasen HFA, Gerritsma MA, Gundy CM, Janssen EPA, et al. Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology. 2010;19:289–98.
Google Scholar
Weiss DS. The Impact of Event Scale-Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD (Second Edition). New York: The Guilford Press; 2004, pp 168–89.
Asukai N, Kato H, Kawamura N, Kim Y, Yamamoto K, Kishimoto J, et al. Reliability and validity of the Japanese-language version of the impact of event scale-revised (IES-R-J): four studies of different traumatic events. J Nerv Ment Dis. 2002;190:175–82.
Google Scholar
Thewes B, Meiser B, Hickie IB. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology. 2001;10:459–68.
Google Scholar
Ringwald J, Wochnowski C, Bosse K, Giel KE, Schäffeler N, Zipfel S, et al. Psychological distress, anxiety, and depression of cancer-affected BRCA1/2 mutation carriers: a systematic review. J Genet Couns. 2016;25:880–91.
Google Scholar
Xie Z, Wenger N, Stanton AL, Sepucha K, Kaplan C, Madlensky L, et al. Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: a single-arm trial of personalized risk communication. Psychooncology. 2019;28:2226–32.
Google Scholar
Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, et al. National Society of Genetic Counselors’ Definition Task Force. A new definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force report. J Genet Couns. 2006;15:77–83.
Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, et al. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021;127:1275–85.
Google Scholar
Courtney E, Li ST, Shaw T, Chen Y, Allen JC, Ngeow J. Predictors of next-generation sequencing panel selection using a shared decision-making approach. NPJ Genom Med. 2018;3:11.
Google Scholar
Kiyozumi Y, Nishimura S, Kado N, Higashigawa S, Horiuchi Y, Ishihara E, et al. Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan. J Genet Couns. 2025;34:e70055.
Sa’at H, Lee YK, Yoon SY, Wong SW, Woo YL, Barlow-Stewart K, et al. Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA mutation carriers with breast cancer: a qualitative study. Int J Behav Med. 2022;29:1–13.
Google Scholar
Rising CJ, Wilsnack C, Boyd P, Sleight AG, Hutson SP, Khincha PP, et al. Family communication challenges of adolescents and young adults with Li-Fraumeni syndrome: implications for psychosocial care. Patient Educ Couns. 2022;105:3259–66.
Google Scholar
Anuk D, Tuncer SB, Özkan M, Yazıcı H. Factors associated with psychological distress during genetic counseling in high-risk women with breast cancer in Turkey. Support Care Cancer. 2024;32:359.
Google Scholar
den Heijer M, Seynaeve C, Vanheusden K, Duivenvoorden HJ, Bartels CCM, Menke-Pluymers MBE, et al. Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support. Psychooncology. 2011;20:1317–23.
Google Scholar
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AHJT, van Asperen CJ, Sijmons RH, et al. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet. 2007;71:35–42.
Google Scholar
Wang V, Marsh FH. Ethical principles and cultural integrity in health care delivery: Asian ethnocultural perspectives in genetic services. J Genet Couns. 1992;1:81–92.
Google Scholar
Nakagomi H, Sakamoto I, Hirotsu Y, Amemiya K, Mochizuki H, Inoue M, et al. Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses. Breast Cancer. 2016;23:649–53.
Google Scholar
Chen LS, Li M, Talwar D, Xu L, Zhao M. Chinese Americans’ views and use of family health history: a qualitative study. PLoS One. 2016;11:e0162706.
Google Scholar
Hicks EM, Litwin MS, Maliski SL. Latino men and familial risk communication about prostate cancer. Oncol Nurs Forum. 2014;41:509–16.
Google Scholar
Underhill-Blazey M, Blonquist T, Chittenden A, Pozzar R, Nayak M, Lansang K, et al. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations. J Genet Couns. 2021;30:268–82.
Google Scholar
Macrae L, de Souza AN, Loiselle CG, Wong N. Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study. Hered Cancer Clin Pr. 2013;11:14.
Akiyama M, Ishida N, Takahashi H, Takahashi M, Otsuki A, Sato Y, et al. Screening practices of cancer survivors and individuals whose family or friends had a cancer diagnoses-a nationally representative cross-sectional survey in Japan (INFORM Study 2020). J Cancer Surviv. 2023;17:663–76.
Google Scholar
